earnings
confidence high
sentiment neutral
materiality 0.70
Herbalife Q3 net sales down 6% to $1.4B; adjusted EPS and EBITDA beat high-end guidance
HERBALIFE LTD.
2021-Q3 EPS reported
$3.73
revenue$4,484,800,000
- Net sales of $1.4B, down 6% YoY; reported diluted EPS $1.09, adjusted diluted EPS $1.21, both up ~5% YoY.
- Adjusted EBITDA of $222.4M; adjusted EPS and EBITDA exceeded high end of guidance ranges.
- Reiterated FY2021 outlook: net sales growth 4.5%–8.5%, adjusted EPS $4.55–$4.95, adjusted EBITDA $860M–$910M.
- Repurchased 3.5M shares for $162M in Q3; sales leaders active up 10% YoY ex-China.
- Asia Pacific net sales +11% (India +46%, 5th straight record); N.America two-year stack +38% vs Q3 2019.